Multani Jasjit K

Clinical and Economic Burden of Glaucoma by Disease Severity: A United States Claims-Based Analysis.

Updated estimates showed highest eye-related costs for those with severe disease and disease progression among patients with OAG and OHT.

Economic and Clinical Burden Associated With Intensification of Glaucoma Topical Therapy: A US Claims-based Analysis.

Multiple-drop therapies yielded shorter-lasting benefits with each additional agent and were associated with the increased clinical and economic burden.